Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synexa is a global leader in specialist biomarker and bioanalytical services. It develops, validates, and delivers complex custom-designed assays to support biopharma clients’ clinical milestones. The company’s expertise spans biomarker identification/development, large/small molecule bioanalysis, soluble biomarker analysis using advanced technologies (MSD, LC-MS/MS, ELISA), cell biology (flow cytometry/ELISpot), proteomics/genomics/tissue imaging/translational science. It operates globally with over 200 staff across six laboratory locations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synexa Life Sciences.